Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Incannex Healthcare Inc. (IXHL : NSDQ)

• Company Description    Incannex Healthcare Limited is a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs. Incannex Healthcare Limited is based in MELBOURNE, Australia. Number of Employees: 12

• Price / Volume Information    Yesterday's Closing Price: $3.52 Daily Weekly Monthly 20 Day Moving Average: 309,315 shares Shares Outstanding: 11.97 (millions) Market Capitalization: $42.12 (millions) Beta: 7.22 52 Week High: $49.80 52 Week Low: $2.49 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -7.12% -11.66% 12 Week -29.81% -35.11% Year To Date -67.26% -68.87%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 525 Collins Street - Melbourne,VI 3008 AUS ph: 61-4-0984-0786 fax: - investors@incannex.com http://www.incannex.com

• General Corporate Information    Officers Joel Latham - Chief Executive Officer and President Troy Valentine - Chairman Joseph Swan - Chief Financial Officer Peter Widdows - Director George Anastassov - Director Peer Information Incannex Healthcare Inc. (GSAC) Incannex Healthcare Inc. (CASIF) Incannex Healthcare Inc. (ALCD.) Incannex Healthcare Inc. (OMNN) Incannex Healthcare Inc. (CGPI.) Incannex Healthcare Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 45333F208 SIC: 2834 Fiscal Year Fiscal Year End: June Last Reported Quarter: 03/01/26 Next Expected EPS Date: 10/05/26 Share - Related Items Shares Outstanding: 11.97 Most Recent Split Date: 2.00 (0.03:1) Beta: 7.22 Market Capitalization: $42.12 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.60 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.10 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 10/05/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.56 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 95.14% vs. Previous Quarter: 41.72% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - -81.01 12/31/25 - -114.95 09/30/25 - -196.72 ROA 03/31/26 - -76.11 12/31/25 - -103.38 09/30/25 - -153.63 Current Ratio 03/31/26 - 41.56 12/31/25 - 48.27 09/30/25 - 47.51 Quick Ratio 03/31/26 - - 12/31/25 - 48.27 09/30/25 - 47.51 Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - - 09/30/25 - -398,933.31 Book Value 03/31/26 - 6.29 12/31/25 - 6.14 09/30/25 - 6.65 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00

Powered by Zacks Investment Research ©